You are here: Industry Insights > Manufacturing

News List

Catalent Invests $27M to Commercialize Zydis Ultra contractpharma
March 08, 2019
ODT technology enables the dosage of active ingredient up to four times higher than conventional Zydis ODT.
Numab & Intarcia Enter License Agreement contractpharma
March 07, 2019
Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders
NiTech Solutions Forms Partnership in U.S. contractpharma
March 07, 2019
Teams up with continuous processing and scale-up experts Nalas Engineering
Scancell appoints Head of Research and Head of Manufacturing firstwordpharma
January 22, 2019
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, today announces the appointment of Dr Samantha Paston as Head of Research and Dr Adrian Parry as Head of Manufacturing.
AGC Triples U.S. Biopharma Production Capacity contractpharma
December 27, 2018
AGC Biologics has enhanced its production capacity of biopharmaceutical manufacturing services. The contract development and manufacturing organization (CDMO) plans to install an additional twelve 2,000L single-use
PCI Synthesis to Become SEQENs contractpharma
December 20, 2018
PCI Synthesis, a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, is changing its name to SEQENS.
Orchard & SIRION Enter License Agreement contractpharma
December 17, 2018
Orchard Therapeutics and SIRION Biotech GmbHhave entered into a license agreement, through which Orchard has licensed SIRION’s LentiBOOST™ technology to enhance manufacturing efficiency for certain of Orchard’s ex vivo
Sartorius, Immunochina to advance immunotherapy development biospectrumasia
December 05, 2018
Immunochina will gain preferred access to SSB’s bioprocess technology platform for development, scale-up and production.
Absorption Systems' ACF Bioservices Certified by MHRA contractpharma
November 27, 2018
Absorption Systems and its ACF Bioservicessubsidiary announced that they have been certified by the European Medicines and Healthcare products Regulatory Agency (MHRA).
SEA Vision Launches HarleNir contractpharma
November 27, 2018
Based on its Harlequin blister control system, HarleNIR is a new generation of blister inspection technology that goes beyond visible inspection to provide a chemical analysis

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page